Clinical-pathological implication of human leukocyte antigen-F-positive gastric adenocarcinoma

Journal of Surgical Research

Volumn 184, Issue 2, 2013, Pages 802-806

  Ishigami, Sumiya ^a   Arigami, Takaaki ^a   Setoyama, Testuro ^a   Okumura, Hiroshi ^a   Sasaki, Ken ^a   Uchikado, Yasuto ^a   Kurahara, Hiroshi ^a   Kijima, Yuko ^a   Nishizono, Yuka ^a   Nakajo, Akihiro ^a   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Gastric adenocarcinoma; HLA F; Infiltrating cells; Surgical outcome

Indexed keywords

HLA F ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION;

GASTRIC ADENOCARCINOMA; HLA-F; INFILTRATING CELLS; SURGICAL OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84883865729     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.04.003     Document Type: Article

References (26)

1. D.M. Roder The epidemiology of gastric cancer Gastric Cancer 3 2002 5
2. N. Kakushima, and M. Fujishiro Endoscopic submucosal dissection for gastrointestinal neoplasms World J Gastroenterol 14 2008 2962
3. T. Gotoda, M. Iwasaki, C. Kusano, S. Seewald, and I. Oda Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria Br J Surg 97 2010 868
4. S. Kitano, and N. Shiraishi Current status of laparoscopic gastrectomy for cancer in Japan Surg Endosc 18 2004 182
5. M. Kobayashi, T. Okabayashi, T. Sano, and K. Araki Metastatic bone cancer as a recurrence of early gastric cancer - characteristics and possible mechanisms World J Gastroenterol 11 2005 5587
6. Y.J. Zhang, and J.Y. Fang Molecular staging of gastric cancer J Gastroenterol Hepatol 23 2008 856
7. M. Katoh Epithelial-mesenchymal transition in gastric cancer (Review) Int J Oncol 27 2005 1677
8. J. Wang, Q. Wang, H. Liu, B. Hu, W. Zhou, and Y. Cheng MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer Cancer Lett 297 2010 137
9. G.J. Betts, S.L. Clarke, H.E. Richards, A.J. Godkin, and A.M. Gallimore Regulating the immune response to tumours Adv Drug Deliv Rev 58 2006 948
10. S. Ishigami, S. Natsugoe, and K. Tokuda Tumor-associated macrophage (TAM) infiltration in gastric cancer Anticancer Res 23 2003 4079
11. C. Ferrone, and G. Dranoff Dual roles for immunity in gastrointestinal cancers J Clin Oncol 28 2010 4045
12. S. Ishigami, T. Arigami, and Y. Uenosono Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer Cancer Immunol Immunother 61 2012 1663
13. E.D. Carosella, P. Moreau, J. Le Maoult, M. Le Discorde, J. Dausset, and N. Rouas-Freiss HLA-G molecules: from maternal-fetal tolerance to tissue acceptance Adv Immunol 81 2003 199
14. J.S. Hunt, M.G. Petroff, P. Morales, P. Sedlmayr, D.E. Geraghty, and C. Ober HLA-G in reproduction: studies on the maternal-fetal interface Hum Immunol 61 2000 1113
15. W.H. Yan Human leukocyte antigen-G in cancer: are they clinically relevant? Cancer Lett 311 2011 123
16. M. Benevolo, M. Mottolese, and E. Tremante High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis J Transl Med 9 2011 184
17. T.G. Silva, J.C. Crispim, and F.A. Miranda Expression of the nonclassical HLA-G and HLA-E molecules in laryngeal lesions as biomarkers of tumor invasiveness Histol Histopathol 26 2011 1487
18. S. Ishigami, S. Natsugoe, and F. Miyazono HLA-G expression in gastric cancer Anticancer Res 26 2006 2467
19. Japanese Gastric Cancer Association Japanese gastric cancer treatment guidelines 2010 (ver. 3) Gastric Cancer 14 2011 113
20. Japanese Gastric Cancer Association Japanese Classification of Gastric Carcinoma - 2nd English Edition Gastric Cancer 1 1998 10
21. A. Lin, X. Zhang, Y.Y. Ruan, Q. Wang, W.J. Zhou, and W.H. Yan HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer Lung Cancer 74 2011 504
22. X. Zhang, A. Lin, and J.G. Zhang Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma Int J Cancer 132 2013 82
23. N. Lee, A. Ishitani, and D.E. Geraghty HLA-F is a surface marker on activated lymphocytes Eur J Immunol 40 2010 2308
24. N. Lee, and D.E. Geraghty HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP J Immunol 171 2003 5264
25. E.J. Lepin, J.M. Bastin, and D.S. Allan Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors Eur J Immunol 30 2000 3552
26. K. Noguchi, M. Isogai, E. Kuwada, A. Noguchi, S. Goto, and K. Egawa Detection of anti-HLA-F antibodies in sera from cancer patients Anticancer Res 24 2004 3387